KUALA LUMPUR: Maybank Investment Bank Research has upgraded its outlook on Mah Sing Group Bhd on the back of its new venture into healthcare related products and potential policy-easing measures, which could lift buying interest in properties.
"We raise our TP to MYR0.64 on 0.4x FY21 PBV (based on the updated -2SD of mean) and upgrade Mah Sing to tactical BUY," said the research house.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!